Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii

[Display omitted] To discover potent antibiotics against the Gram-negative bacteria, we performed a structure-activity relationship (SAR) study of YKsa-6, which was the most potent inhibitor of Staphylococcus aureus β-ketoacyl acyl carrier protein III in our previous study. We identified and selecte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2017-01, Vol.25 (1), p.372-380
Hauptverfasser: Lee, Jee-Young, Jeong, Min-Cheol, Jeon, Dasom, Lee, Yeongjun, Lee, Woo Cheol, Kim, Yangmee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 380
container_issue 1
container_start_page 372
container_title Bioorganic & medicinal chemistry
container_volume 25
creator Lee, Jee-Young
Jeong, Min-Cheol
Jeon, Dasom
Lee, Yeongjun
Lee, Woo Cheol
Kim, Yangmee
description [Display omitted] To discover potent antibiotics against the Gram-negative bacteria, we performed a structure-activity relationship (SAR) study of YKsa-6, which was the most potent inhibitor of Staphylococcus aureus β-ketoacyl acyl carrier protein III in our previous study. We identified and selected 11 candidates, and finally screened two active compounds, YKab-4 (4-[(3-chloro-4-methylphenyl)aminoiminomethyl]benzene-1,3-diol) and YKab-6 (4-[[3-(trifluoromethyl)phenyl]aminoiminomethyl]phenol) as inhibitors of Acinetobacter baumannii KAS III (abKAS III). They showed potent antimicrobial activities at 2 or 8 μg/mL, specifically against Acinetobacter baumannii and a strong binding affinity for abKAS III. From the homology modeling, we defined the three-dimensional (3D) structure of abKAS III for the first time and found that it had an extra loop region compared with common Gram-negative bacteria derived KAS IIIs. The docking study revealed that the hydroxyl groups of inhibitors formed extensive hydrogen bonds and the complicated hydrophobic and cation-stacking interactions are important to binding with abKAS III. We confirmed that the hydrophobicity of these compounds might be the essential factor for their antimicrobial activities against Gram-negative bacteria as well as their structural rigidity, a cooperative feature for retaining the hydrophobic interactions between abKAS III and its inhibitors. This study may provide an insight developing strategies for potent antibiotics against A. baumannii.
doi_str_mv 10.1016/j.bmc.2016.11.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1839127471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089616311038</els_id><sourcerecordid>1839127471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-9d1b064efc468f97db97426c931bad0559911d8d9750b5645924b7513be475fb3</originalsourceid><addsrcrecordid>eNp9kM1u1DAURi1ERYeWB2CDsmST4Js4TixWVQUFqRKL0rXln5vhjhJnsJ2R-va4msKSle_ifEfyYew98AY4yE-Hxi6uacvZADScwyu2AyFF3XUKXrMdV3Ks-ajkJXub0oFz3goFb9hlO4yCQyd3bH7IcXN5i1gbl-lE-amKOJtMa0i_6Fhbk9BXyUXEQGFfrVNlQiZLayaXKrM3FFKu7qJZ6oD7MjxhdeMoYF5tUWKsrNkWEwLRNbuYzJzw3ct7xR6_fvl5-62-_3H3_fbmvnZd3-VaebBcCpyckOOkBm_VIFrpVAfWeN73SgH40auh57aXoletsEMPnUUx9JPtrtjHs_cY198bpqwXSg7n2QRct6RhLH3aQQxQUDijLq4pRZz0MdJi4pMGrp8j64MukfVzZA2gS-Sy-fCi3-yC_t_ib9UCfD4DWD55Iow6OcLg0FNEl7Vf6T_6P2f6jls</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1839127471</pqid></control><display><type>article</type><title>Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lee, Jee-Young ; Jeong, Min-Cheol ; Jeon, Dasom ; Lee, Yeongjun ; Lee, Woo Cheol ; Kim, Yangmee</creator><creatorcontrib>Lee, Jee-Young ; Jeong, Min-Cheol ; Jeon, Dasom ; Lee, Yeongjun ; Lee, Woo Cheol ; Kim, Yangmee</creatorcontrib><description>[Display omitted] To discover potent antibiotics against the Gram-negative bacteria, we performed a structure-activity relationship (SAR) study of YKsa-6, which was the most potent inhibitor of Staphylococcus aureus β-ketoacyl acyl carrier protein III in our previous study. We identified and selected 11 candidates, and finally screened two active compounds, YKab-4 (4-[(3-chloro-4-methylphenyl)aminoiminomethyl]benzene-1,3-diol) and YKab-6 (4-[[3-(trifluoromethyl)phenyl]aminoiminomethyl]phenol) as inhibitors of Acinetobacter baumannii KAS III (abKAS III). They showed potent antimicrobial activities at 2 or 8 μg/mL, specifically against Acinetobacter baumannii and a strong binding affinity for abKAS III. From the homology modeling, we defined the three-dimensional (3D) structure of abKAS III for the first time and found that it had an extra loop region compared with common Gram-negative bacteria derived KAS IIIs. The docking study revealed that the hydroxyl groups of inhibitors formed extensive hydrogen bonds and the complicated hydrophobic and cation-stacking interactions are important to binding with abKAS III. We confirmed that the hydrophobicity of these compounds might be the essential factor for their antimicrobial activities against Gram-negative bacteria as well as their structural rigidity, a cooperative feature for retaining the hydrophobic interactions between abKAS III and its inhibitors. This study may provide an insight developing strategies for potent antibiotics against A. baumannii.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2016.11.001</identifier><identifier>PMID: 27840136</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>3-Oxoacyl-(Acyl-Carrier-Protein) Synthase - antagonists &amp; inhibitors ; Acinetobacter baumannii - drug effects ; Animals ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Antibiotics ; Cell Line, Tumor ; Drug Evaluation, Preclinical ; Fatty acid synthesis ; Gram-negative bacteria ; Hydrazones - chemistry ; Hydrazones - pharmacology ; Hydrogen Bonding ; Hydrophobic and Hydrophilic Interactions ; In silico screening ; KAS ; Mice ; Molecular Docking Simulation ; Nitrites - metabolism ; Phenols - chemistry ; Phenols - pharmacology ; Resorcinols - chemistry ; Resorcinols - pharmacology ; RNA, Messenger - metabolism ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2017-01, Vol.25 (1), p.372-380</ispartof><rights>2016</rights><rights>Copyright © 2016. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-9d1b064efc468f97db97426c931bad0559911d8d9750b5645924b7513be475fb3</citedby><cites>FETCH-LOGICAL-c353t-9d1b064efc468f97db97426c931bad0559911d8d9750b5645924b7513be475fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2016.11.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27840136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Jee-Young</creatorcontrib><creatorcontrib>Jeong, Min-Cheol</creatorcontrib><creatorcontrib>Jeon, Dasom</creatorcontrib><creatorcontrib>Lee, Yeongjun</creatorcontrib><creatorcontrib>Lee, Woo Cheol</creatorcontrib><creatorcontrib>Kim, Yangmee</creatorcontrib><title>Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted] To discover potent antibiotics against the Gram-negative bacteria, we performed a structure-activity relationship (SAR) study of YKsa-6, which was the most potent inhibitor of Staphylococcus aureus β-ketoacyl acyl carrier protein III in our previous study. We identified and selected 11 candidates, and finally screened two active compounds, YKab-4 (4-[(3-chloro-4-methylphenyl)aminoiminomethyl]benzene-1,3-diol) and YKab-6 (4-[[3-(trifluoromethyl)phenyl]aminoiminomethyl]phenol) as inhibitors of Acinetobacter baumannii KAS III (abKAS III). They showed potent antimicrobial activities at 2 or 8 μg/mL, specifically against Acinetobacter baumannii and a strong binding affinity for abKAS III. From the homology modeling, we defined the three-dimensional (3D) structure of abKAS III for the first time and found that it had an extra loop region compared with common Gram-negative bacteria derived KAS IIIs. The docking study revealed that the hydroxyl groups of inhibitors formed extensive hydrogen bonds and the complicated hydrophobic and cation-stacking interactions are important to binding with abKAS III. We confirmed that the hydrophobicity of these compounds might be the essential factor for their antimicrobial activities against Gram-negative bacteria as well as their structural rigidity, a cooperative feature for retaining the hydrophobic interactions between abKAS III and its inhibitors. This study may provide an insight developing strategies for potent antibiotics against A. baumannii.</description><subject>3-Oxoacyl-(Acyl-Carrier-Protein) Synthase - antagonists &amp; inhibitors</subject><subject>Acinetobacter baumannii - drug effects</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Antibiotics</subject><subject>Cell Line, Tumor</subject><subject>Drug Evaluation, Preclinical</subject><subject>Fatty acid synthesis</subject><subject>Gram-negative bacteria</subject><subject>Hydrazones - chemistry</subject><subject>Hydrazones - pharmacology</subject><subject>Hydrogen Bonding</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>In silico screening</subject><subject>KAS</subject><subject>Mice</subject><subject>Molecular Docking Simulation</subject><subject>Nitrites - metabolism</subject><subject>Phenols - chemistry</subject><subject>Phenols - pharmacology</subject><subject>Resorcinols - chemistry</subject><subject>Resorcinols - pharmacology</subject><subject>RNA, Messenger - metabolism</subject><subject>Structure-Activity Relationship</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1u1DAURi1ERYeWB2CDsmST4Js4TixWVQUFqRKL0rXln5vhjhJnsJ2R-va4msKSle_ifEfyYew98AY4yE-Hxi6uacvZADScwyu2AyFF3XUKXrMdV3Ks-ajkJXub0oFz3goFb9hlO4yCQyd3bH7IcXN5i1gbl-lE-amKOJtMa0i_6Fhbk9BXyUXEQGFfrVNlQiZLayaXKrM3FFKu7qJZ6oD7MjxhdeMoYF5tUWKsrNkWEwLRNbuYzJzw3ct7xR6_fvl5-62-_3H3_fbmvnZd3-VaebBcCpyckOOkBm_VIFrpVAfWeN73SgH40auh57aXoletsEMPnUUx9JPtrtjHs_cY198bpqwXSg7n2QRct6RhLH3aQQxQUDijLq4pRZz0MdJi4pMGrp8j64MukfVzZA2gS-Sy-fCi3-yC_t_ib9UCfD4DWD55Iow6OcLg0FNEl7Vf6T_6P2f6jls</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Lee, Jee-Young</creator><creator>Jeong, Min-Cheol</creator><creator>Jeon, Dasom</creator><creator>Lee, Yeongjun</creator><creator>Lee, Woo Cheol</creator><creator>Kim, Yangmee</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii</title><author>Lee, Jee-Young ; Jeong, Min-Cheol ; Jeon, Dasom ; Lee, Yeongjun ; Lee, Woo Cheol ; Kim, Yangmee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-9d1b064efc468f97db97426c931bad0559911d8d9750b5645924b7513be475fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>3-Oxoacyl-(Acyl-Carrier-Protein) Synthase - antagonists &amp; inhibitors</topic><topic>Acinetobacter baumannii - drug effects</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Antibiotics</topic><topic>Cell Line, Tumor</topic><topic>Drug Evaluation, Preclinical</topic><topic>Fatty acid synthesis</topic><topic>Gram-negative bacteria</topic><topic>Hydrazones - chemistry</topic><topic>Hydrazones - pharmacology</topic><topic>Hydrogen Bonding</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>In silico screening</topic><topic>KAS</topic><topic>Mice</topic><topic>Molecular Docking Simulation</topic><topic>Nitrites - metabolism</topic><topic>Phenols - chemistry</topic><topic>Phenols - pharmacology</topic><topic>Resorcinols - chemistry</topic><topic>Resorcinols - pharmacology</topic><topic>RNA, Messenger - metabolism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Jee-Young</creatorcontrib><creatorcontrib>Jeong, Min-Cheol</creatorcontrib><creatorcontrib>Jeon, Dasom</creatorcontrib><creatorcontrib>Lee, Yeongjun</creatorcontrib><creatorcontrib>Lee, Woo Cheol</creatorcontrib><creatorcontrib>Kim, Yangmee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Jee-Young</au><au>Jeong, Min-Cheol</au><au>Jeon, Dasom</au><au>Lee, Yeongjun</au><au>Lee, Woo Cheol</au><au>Kim, Yangmee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>25</volume><issue>1</issue><spage>372</spage><epage>380</epage><pages>372-380</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted] To discover potent antibiotics against the Gram-negative bacteria, we performed a structure-activity relationship (SAR) study of YKsa-6, which was the most potent inhibitor of Staphylococcus aureus β-ketoacyl acyl carrier protein III in our previous study. We identified and selected 11 candidates, and finally screened two active compounds, YKab-4 (4-[(3-chloro-4-methylphenyl)aminoiminomethyl]benzene-1,3-diol) and YKab-6 (4-[[3-(trifluoromethyl)phenyl]aminoiminomethyl]phenol) as inhibitors of Acinetobacter baumannii KAS III (abKAS III). They showed potent antimicrobial activities at 2 or 8 μg/mL, specifically against Acinetobacter baumannii and a strong binding affinity for abKAS III. From the homology modeling, we defined the three-dimensional (3D) structure of abKAS III for the first time and found that it had an extra loop region compared with common Gram-negative bacteria derived KAS IIIs. The docking study revealed that the hydroxyl groups of inhibitors formed extensive hydrogen bonds and the complicated hydrophobic and cation-stacking interactions are important to binding with abKAS III. We confirmed that the hydrophobicity of these compounds might be the essential factor for their antimicrobial activities against Gram-negative bacteria as well as their structural rigidity, a cooperative feature for retaining the hydrophobic interactions between abKAS III and its inhibitors. This study may provide an insight developing strategies for potent antibiotics against A. baumannii.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27840136</pmid><doi>10.1016/j.bmc.2016.11.001</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2017-01, Vol.25 (1), p.372-380
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_1839127471
source MEDLINE; Elsevier ScienceDirect Journals
subjects 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase - antagonists & inhibitors
Acinetobacter baumannii - drug effects
Animals
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Anti-Inflammatory Agents, Non-Steroidal - chemistry
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
Antibiotics
Cell Line, Tumor
Drug Evaluation, Preclinical
Fatty acid synthesis
Gram-negative bacteria
Hydrazones - chemistry
Hydrazones - pharmacology
Hydrogen Bonding
Hydrophobic and Hydrophilic Interactions
In silico screening
KAS
Mice
Molecular Docking Simulation
Nitrites - metabolism
Phenols - chemistry
Phenols - pharmacology
Resorcinols - chemistry
Resorcinols - pharmacology
RNA, Messenger - metabolism
Structure-Activity Relationship
title Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A37%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure-activity%20relationship-based%20screening%20of%20antibiotics%20against%20Gram-negative%20Acinetobacter%20baumannii&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Lee,%20Jee-Young&rft.date=2017-01-01&rft.volume=25&rft.issue=1&rft.spage=372&rft.epage=380&rft.pages=372-380&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2016.11.001&rft_dat=%3Cproquest_cross%3E1839127471%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1839127471&rft_id=info:pmid/27840136&rft_els_id=S0968089616311038&rfr_iscdi=true